Doses of 40 ixg/kg according to Harrison et al., and 100-120 ixg/kg according to the Israeli Task Force and the European Consensus, were reported as effective for controlling trauma-associated coagulopathy, decreasing the number of units required and reducing mortality.
Dosis de 40 ixg/kg para Harrison et al., y de 100-120 μg/kg para el Task Force Israelí y el Consenso Europeo, fueron referidas como efectivas para controlar la coagulopatía relacionada con trauma, disminuir la cantidad de unidades requeridas y la mortalidad.